Monsanto Co. (NYSE:MON) updated its FY17 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $4.50-4.90 for the period, compared to the Thomson Reuters consensus estimate of $4.92.

Several research analysts recently issued reports on the company. Goldman Sachs Group Inc. raised Monsanto from a sell rating to a neutral rating and set a $104.00 target price on the stock in a research report on Tuesday, September 27th. Jefferies Group reissued a buy rating on shares of Monsanto in a research report on Wednesday, June 29th. Piper Jaffray Cos. set a $128.00 price objective on Monsanto and gave the stock a buy rating in a research report on Thursday, September 15th. Citigroup Inc. reissued a neutral rating and issued a $112.00 price objective (up previously from $94.00) on shares of Monsanto in a research report on Friday, July 1st. Finally, Zacks Investment Research raised Monsanto from a sell rating to a hold rating in a research report on Wednesday, June 8th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average price target of $114.21.

Earnings History and Estimates for Monsanto (NYSE:MON)

Shares of Monsanto Co. (NYSE:MON) opened at 101.61 on Wednesday. Monsanto Co. has a one year low of $83.73 and a one year high of $114.26. The stock has a market capitalization of $44.46 billion, a PE ratio of 44.72 and a beta of 1.19. The company’s 50-day moving average price is $104.97 and its 200 day moving average price is $101.31.

Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 37.98% and a net margin of 7.76%. The business had revenue of $2.56 billion for the quarter, compared to the consensus estimate of $2.38 billion. During the same period in the previous year, the business earned ($0.19) earnings per share. The business’s revenue was up 8.8% on a year-over-year basis. Analysts anticipate that Monsanto Co. will post $4.46 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be issued a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.11%. Monsanto’s dividend payout ratio (DPR) is 89.26%.

In other news, COO Brett D. Begemann sold 27,980 shares of Monsanto stock in a transaction dated Thursday, July 14th. The stock was sold at an average price of $103.62, for a total value of $2,899,287.60. Following the sale, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at $10,618,977.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Michael K. Stern sold 12,797 shares of Monsanto stock in a transaction dated Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the sale, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is owned by insiders.

Several large investors have recently modified their holdings of MON. FMR LLC boosted its stake in shares of Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock valued at $1,715,960,000 after buying an additional 4,851,499 shares during the period. Third Point LLC bought a new stake in shares of Monsanto during the second quarter valued at $206,820,000. TIAA CREF Investment Management LLC boosted its stake in shares of Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock valued at $481,732,000 after buying an additional 1,560,646 shares during the last quarter. Senator Investment Group LP bought a new stake in shares of Monsanto during the second quarter valued at $82,728,000. Finally, Teachers Advisors Inc. boosted its stake in shares of Monsanto by 46.7% in the second quarter. Teachers Advisors Inc. now owns 1,814,167 shares of the company’s stock valued at $187,603,000 after buying an additional 577,685 shares during the last quarter. 79.02% of the stock is currently owned by hedge funds and other institutional investors.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.